Wheel, which provides tools enabling health providers or employers to offer telehealth services, raises $50M Series B led by Lightspeed Venture Partners
Katie Jennings / Forbes : Tweets: @forbesunder30 Tweets: @forbesunder30 : “The vision of Wheel is really about expanding access,” says cofounder and CEO Michelle Davey. “It's about connecting patients to the right care for them, when they need it most.” https://www.forbes.com/...
Context & Ripple Effects
Wheel is scaling fast along its own funding curve: the company raised a $13.9M Series A led by CRV in early 2020 as a marketplace matching doctors and nurse practitioners to telemedicine companies, and this $50M Series B — now led by Lightspeed Venture Partners — marks the shift from matchmaking toward powering telehealth end-to-end for health providers and employers.
The raise lands in a crowded but well-funded lane: Tyto Care pulled in $50M in 2020 for remote-diagnosis hardware, and two weeks before this round Headway raised a $70M Series B at a $750M valuation for insurance-covered therapy access. The pattern across coverage is investors funding different layers of the same care-delivery rebuild — devices, clinician supply, and now the white-label infrastructure layer Wheel occupies.
First-order effects
- Lightspeed's check gives CEO Michelle Davey capital to push Wheel's 'connect patients to the right care' vision beyond its clinician-marketplace roots, targeting health systems and employers that want telehealth without building it themselves.
- The round validates the pivot visible between the Series A and B: from selling access to clinicians into selling the full operating layer, which changes who Wheel competes with — no longer just staffing marketplaces but any platform a provider or employer might otherwise license.
Second-order effects
- Employers and health providers evaluating telehealth vendors now face a funded, dedicated infrastructure option, pressuring adjacent plays like Tyto Care's hardware-led model to prove their kits integrate with platforms like Wheel's rather than substitute for them.
- Rapid step-ups in round size — $13.9M to $50M, then a $150M Series C within eight months bringing total funding to $216M — signal that competing telehealth infrastructure startups face rising capital requirements just to stay in the procurement conversation.
Third-order effects
- If the funding cadence holds, telehealth consolidates into layered specialists — clinician networks (Wheel), diagnostic hardware (Tyto Care), insurance-navigated behavioral health (Headway) — with health systems and employers assembling care stacks from vendors instead of building internally.
- Sustained investor appetite for this layer points toward telehealth becoming standard purchased infrastructure, where differentiation shifts from whether virtual care is offered to whose platform routes patients to it.
The trend: Healthcare is being rebuilt as buyable layers — clinician supply, diagnostics, payment navigation — and Wheel's accelerating rounds show infrastructure platforms absorbing capital fastest.